Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

158
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
158
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

701
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
701
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial.

Journal of the American Heart Association·2026
Same author

Constrictive Pericarditis and Bilateral Pleural Effusions Unmasked in an HLA-B27 Positive Patient.

JACC. Case reports·2026
Same author

Recurrent Pericarditis Evolving to Constrictive Pericarditis and Pericardiectomy Over 18 Years.

JACC. Case reports·2026
Same author

Managing Refractory Pericarditis in the Era of Biologic Therapy: A Cardio-Oncology-Based Risk Framework.

JACC. Advances·2026
Same author

Application of 2025 American Society of Echocardiography Guideline in Heart Failure With Preserved Ejection Fraction: Limitations of Left Atrial Volume Index and Left Atrial Reservoir Strain as Single Markers of Filling Pressure.

Journal of the American College of Cardiology·2026
Same author

Myxoid Pleomorphic Liposarcoma Imitating Recurrent Traumatic Hemopericardium.

JACC. Case reports·2026

相关实验视频

Updated: Jun 14, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.4K

恶性心周溢血:一个系统性审查.

Sarah E Mudra1, Danny Rayes1, Ashwin K Kumar1,2

  • 1Department of Internal Medicine, MedStar Georgetown University Hospital, MedStar Health, Washington, DC, USA.

CJC open
|August 30, 2024
PubMed
概括

恶性心周溢血往往是严重的,大多数患者经历心脏吸管. 这一系统性审查强调了有限的治疗选择和高死亡率,主要是由于癌症进展.

更多相关视频

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.2K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

相关实验视频

Last Updated: Jun 14, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.4K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.2K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

科学领域:

  • 在瘤学瘤学.
  • 心脏病学 心脏病学
  • 内部医学 内部医学

背景情况:

  • 恶性心周溢血 (MPE) 是一种严重的疾病,通常是晚诊断的,由于无症状呈现,患病率不明.
  • 关于MPE的流行病学,临床特征和结果的文献有限.
  • 本系统性审查旨在改善对癌症患者MPE的理解.

研究的目的:

  • 进行恶性心周溢液的系统审查.
  • 分析流行病学数据,临床特征和结果.
  • 为MPE的管理和预后提供见解.

主要方法:

  • 在4个数据库中系统搜索案例报告.
  • 纳入标准:患有心周溢血和恶性瘤的18岁以上患者.
  • 数据提取的重点是干预和死亡率.

主要成果:

  • 包括41个病例报告,中位数年龄54岁,58%是男性.
  • 呼吸不全 (90%) 和心脏吸管 (78%) 是常见的症状.
  • 肺癌,肠道癌和癌是最常见的;44%的死亡率,主要来自疾病进展.

结论:

  • 这是迄今为止对MPE进行的最大的系统审查.
  • 固体瘤,特别是肺腺癌,是常见的原因.
  • MPE是严重的,经常呈现出心脏栓塞,有限的治疗选择和高死亡率.